Collaborative Acceleration: PROLIFIC Consortium Update on Advancing PF Research Through Real-World Data & Biomarker Integration
- Explore how the PROLIFIC Consortium is leveraging longitudinal clinical data and biosamples across diverse care settings to refine our understanding of pulmonary fibrosis progression and treatment outcomes
- Get the latest updates on multi-center efforts to identify, validate, and implement biomarkers that can predict progression, inform trial design, and personalize care
- Understand how this industry-funded initiative is creating a robust framework to support open science, harmonized data collection, and future clinical trials by bringing together academic centers, biobanks, and industry partners